Yeji
CRLconf 0.70

ux111 — CRL

$RARE · Ultragenyx Pharmaceutical Inc. · Sanfilippo syndrome Type A (MPS IIIA)
Event date
July 1, 2025
340 days ago
Sponsor runway
3 mo
$175.0M liquid

Evidence

“The resubmitted BLA includes comprehensive responses to chemistry, manufacturing, and controls (CMC)-related observations outlined in a Complete Response Letter (the "CRL") issued in July 2025”
Source: 8-K filed 2026-01-30View on EDGAR ↗0001193125-26-030590

Comparable historical crls· last 5 years · same event type

No comparable historical outcomes in our database yet — backfill of past readouts arrives next ingestion cycle.

Recent insider activity· ±90 days

10 insiders · 0 buys · 6 sells
Sell
2025-09-18
Huizenga Theodore Alan
SVP, Chief Accounting Officer
64 @ $29.17$2K
Sell
2025-09-12
Parschauer Karah Herdman
EVP and Chief Legal Officer
2,450 @ $31.17$76K
Sell
2025-09-05
Huizenga Theodore Alan
SVP, Chief Accounting Officer
84 @ $31.39$3K
Sell10b5-1
2025-06-20
Sanders Corazon (Corsee) D.
Director
2,405 @ $37.39$90K
Grant
2025-05-15
NARACHI MICHAEL
Director
5,740 @ ——
Grant
2025-05-15
NARACHI MICHAEL
Director
10,787 @ ——
Grant
2025-05-15
Ray Amrit
Director
5,740 @ ——
Grant
2025-05-15
Ray Amrit
Director
10,787 @ ——
Grant
2025-05-15
Fust Matthew K
Director
5,740 @ ——
Grant
2025-05-15
Fust Matthew K
Director
10,787 @ ——
Grant
2025-05-15
SULIMAN SHEHNAAZ
Director
5,740 @ ——
Grant
2025-05-15
SULIMAN SHEHNAAZ
Director
10,787 @ ——
Grant
2025-05-15
WELCH DANIEL G
Director
5,740 @ ——
Grant
2025-05-15
WELCH DANIEL G
Director
10,787 @ ——
Grant
2025-05-15
Dunsire Deborah
Director
5,740 @ ——
Grant
2025-05-15
Dunsire Deborah
Director
10,787 @ ——
Grant
2025-05-15
Sanders Corazon (Corsee) D.
Director
5,740 @ ——
Grant
2025-05-15
Sanders Corazon (Corsee) D.
Director
10,787 @ ——
Sell
2025-05-05
Crombez Eric
EVP and Chief Medical Officer
520 @ $39.24$20K
Sell
2025-04-21
Crombez Eric
EVP and Chief Medical Officer
242 @ $35.11$8K
← All catalysts for $RARE